Matias R. Chacon

1180 Crámer St
B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Representation of Patients From South America in Sarcoma Clinical Trials.

Representation of Patients From South America in Sarcoma Clinical Trials.

Journal: JAMA network open

Published: June 11, 2026

Early tumor-informed circulating tumor DNA (ctDNA) dynamics correlate with response to first-line advanced NSCLC treated with pembrolizumab ± chemotherapy.

Early tumor-informed circulating tumor DNA (ctDNA) dynamics correlate with response to first-line advanced NSCLC treated with pembrolizumab ± chemotherapy.

Journal: The journal of liquid biopsy

Published: May 29, 2026

Corrigendum to 'Subcutaneous versus intravenous nivolumab for renal cell carcinoma': [Annals of Oncology volume 36 (2025) 99-107].

Corrigendum to 'Subcutaneous versus intravenous nivolumab for renal cell carcinoma': [Annals of Oncology volume 36 (2025) 99-107].

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: May 07, 2026

Histopathologic Diagnostic Agreement Study in Bone and Soft Tissue Tumors: The SELNET Sarcoma Network Experience.

Histopathologic Diagnostic Agreement Study in Bone and Soft Tissue Tumors: The SELNET Sarcoma Network Experience.

Journal: JCO global oncology

Published: December 15, 2025

Initial report from the SAR-TRACK (SELNET) registry: a multicentric international retrospective analysis on the quality of the management of limb and trunk wall soft-tissue sarcomas (2012-2022) in Ibero-American countries.

Initial report from the SAR-TRACK (SELNET) registry: a multicentric international retrospective analysis on the quality of the management of limb and trunk wall soft-tissue sarcomas (2012-2022) in Ibero-American countries.

Journal: Lancet regional health. Americas

Published: September 30, 2025

Pharmacokinetics and safety of subcutaneous nivolumab: results from the phase I/II CheckMate 8KX study.

Pharmacokinetics and safety of subcutaneous nivolumab: results from the phase I/II CheckMate 8KX study.

Journal: Journal for immunotherapy of cancer

Published: August 27, 2025

Sinonasal Sarcomas Management: An International Consensus Statement.

Sinonasal Sarcomas Management: An International Consensus Statement.

Journal: International forum of allergy & rhinology

Published: August 26, 2025

Physician treatment decisions for hormone receptor-positive, HER2-negative early breast cancer in young patients: a Latin American survey.

Physician treatment decisions for hormone receptor-positive, HER2-negative early breast cancer in young patients: a Latin American survey.

Journal: Therapeutic advances in medical oncology

Published: May 01, 2025

Patients with Colorectal Cancer and BRAFV600E-Mutation in Argentina: A Real-World Study-The EMOGI-CRC01 Study.

Patients with Colorectal Cancer and BRAFV600E-Mutation in Argentina: A Real-World Study-The EMOGI-CRC01 Study.

Journal: Cancers

Published: January 19, 2025

Assessment of Rare Cancers and Sarcoma Policy and Sarcoma Drug Approvals in Latin America: A Report From the LACOG Sarcoma Group.

Assessment of Rare Cancers and Sarcoma Policy and Sarcoma Drug Approvals in Latin America: A Report From the LACOG Sarcoma Group.

Journal: JCO global oncology

Published: January 17, 2025

Maintenance therapy after first-line platinum-based chemotherapy in gastroenteropancreatic neuroendocrine carcinomas: A literature review.

Maintenance therapy after first-line platinum-based chemotherapy in gastroenteropancreatic neuroendocrine carcinomas: A literature review.

Journal: Cancer treatment reviews

Published: October 11, 2024

Subcutaneous versus intravenous nivolumab for renal cell carcinoma.

Subcutaneous versus intravenous nivolumab for renal cell carcinoma.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: July 25, 2024

Showing 1-12 of 55

Last Updated: 09/26/2026